Sign In
Buy BEAT
$0.710
-0.0495 (-6.52%)
At Close: Jun 22, 2026
HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
08:31am, Thursday, 01'st May 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time.
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
08:31am, Tuesday, 29'th Apr 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology.
HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation
08:31am, Thursday, 24'th Apr 2025
SANTA CLARA, Calif. & NEW YORK--(BUSINESS WIRE)--HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation.
HeartBeam, Inc. (BEAT) Q4 2024 Earnings Call Transcript
09:02pm, Thursday, 13'th Mar 2025
HeartBeam, Inc. (NASDAQ:BEAT ) Q4 2024 Results Conference Call March 13, 2025 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Tim Cruickshank - Chief Financial Officer Operator Greet
HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
09:01am, Thursday, 06'th Mar 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 17-21, 2025.
HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock
04:01pm, Tuesday, 25'th Feb 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Exercise and Closing of Underwriter's Over-Allotment Option for Public Offering of Common Stock.
HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock
08:31am, Thursday, 13'th Feb 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock.
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
08:31am, Wednesday, 29'th Jan 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software.
HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference
08:31am, Monday, 23'rd Dec 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference.
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
08:31am, Monday, 16'th Dec 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology.
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
08:31am, Tuesday, 19'th Nov 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference.
HeartBeam, Inc. (BEAT) Q3 2024 Earnings Call Transcript
09:22pm, Saturday, 09'th Nov 2024
HeartBeam, Inc. (NASDAQ:BEAT ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Rob Eno - Chief Executive Officer Branislav Vajdic - President and Founder Tim Cruicksh
HeartBeam Reports Third Quarter 2024 Results
04:05pm, Thursday, 07'th Nov 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Third Quarter 2024 Results.
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time
08:31am, Thursday, 31'st Oct 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 4:30 p.m. Eastern Time.
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
08:31am, Thursday, 24'th Oct 2024
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards.
